Diabetes Metab J.
2019 Oct;43(5):731-731. 10.4093/dmj.2019.0188.
Corrigenda: Table Correction. Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- 2Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
- 3Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
- 4Department of Internal Medicine, Wonkwang University Hospital, Wonkwang University School of Medicine, Iksan, Korea.
- KMID: 2460967
- DOI: http://doi.org/10.4093/dmj.2019.0188
Abstract
- In this article, the description of one equation named "NAFLD liver fat score" in the Table 3 was miswritten.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
- Nonalcoholic Steatohepatitis
- Epidemiology of Nonalcoholic Fatty Liver Disease: Focusing on the Korean Genome Epidemiology Study (KoGES)
- Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease
